Representing clients who are shaping the future

Industry research has forecast the global legal cannabis market will surpass $134B by 2030

The Cannabis Industry is approximately a decade old. During that decade, the industry has grown, evolved, and now is settling into a mature industry. The approach and skill sets that defined the industry’s first decade are no longer necessarily what will work in the industry’s second decade.

As a growing and thriving industry, cannabis poses complex challenges throughout a variety of industries and markets. Sullivan’s Cannabis Group provides its clients with comprehensive legal services and assists them in achieving their business goals through deep knowledge and understanding of the cannabis industry around the world.

Our Cannabis Group is comprised of attorneys spanning multiple practice groups and offices and includes one of the first general counsels of a publicly-traded cannabis company. Members of our Cannabis Group handled some of the first financings and license applications for state-legal cannabis companies.

As laws evolve and ground-breaking decisions are made, businesses and employers face unique issues surrounding this thriving and ever-changing industry. Our lawyers advise on legal and regulatory requirements and risk management. We’ve designed our cannabis practice to meet the unique needs, challenges and opportunities of our cannabis clients with unrivaled industry knowledge.

Our clients include entrepreneurs as well as private and public companies, including:

• Investors
• Venture capital funds
• Medical cannabis cultivators
• R&D companies specializing in medical cannabis-based products, medicines and complementary products
• Manufacturing and processing companies

Our areas of expertise include:

• Emerging companies and venture capital
• Capital markets
• Mergers and acquisitions
• Fund formation
• Intellectual property
• Government relations
• Regulatory compliance
• Real estate, including Reits
• Tax
• Employment and benefits
• Litigation and dispute resolution
• Restructurings and bankruptcy

Representative Client Work

• Represent a cannabis consulting company in connection with a strategic transaction
• Represent a biotechnology company in connection with a NASDAQ listing
• Represent a cannabis technology company in connection with a capital raising transaction
• Represented an early private investor in a publicly-traded Canadian cannabis company
• Represented a foreign holding company in a share purchase agreement with a company in the medical cannabis field
• Represented a foreign holding company in a share purchase agreement with a company operation for the development of a medicine/drug in the medical cannabis field
• Representing a private investor in a share purchase agreement in an aggregate amount of €5,000,000 with a company operating to grow and cultivate cannabis in Spain
• Representing a private investor in negotiations for an investment in the field of medical cannabis in Macedonia
• Representing a foreign holding company in negotiations for an investment in a company operating to extract oils from cannabis in Europe
• Representing a Mexican company in negotiations for an investment in the amount of $80 million in the medical cannabis field
• Represented private investors in a share purchase agreement with a company in the medical cannabis field
• Represented private investors in a second round of investment in a company in the medical cannabis field
• Represented a private investor in a share purchase agreement with a company in the medical cannabis field
• Represented a private investor of MedReleaf Corp., a public company traded on the Toronto Stock Exchange, in the sale of MedReleaf Corp to Aurora Cannabis Inc.
• Represented The Can Leaf Group in an investment for the establishment of a medical cannabis activity in a kibbutz in the south of Israel